Publications en collaboration avec des chercheurs de PharmaMar (1)

2019

  1. Safety and tolerability of lurbinectedin (PM01183) in patients with acute myeloid leukemia and myelodysplastic syndrome

    Hematological Oncology, Vol. 37, Núm. 1, pp. 96-102